Published in Antibiot Khimioter on May 01, 1994
Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. J Clin Virol (2009) 1.24
Suppression of influenza virus replication in infected mice by protease inhibitors. J Gen Virol (1984) 1.17
Two forms of influenza virus nucleoprotein in infected cells and virions. Virology (1981) 1.15
Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol (2005) 1.11
A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells. FEBS Lett (1990) 0.98
The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc Natl Acad Sci U S A (1999) 0.95
A modified plaque assay method for accurate analysis of infectivity of influenza viruses with uncleaved hemagglutinin. Arch Virol (1982) 0.94
Protein synthesis in Sendai virus-infected cells. J Gen Virol (1975) 0.93
Myxovirus replication in chicken embryos can be suppressed by aprotinin due to the blockage of viral glycoprotein cleavage. J Gen Virol (1985) 0.92
High protection of animals lethally infected with influenza virus by aprotinin-rimantadine combination. J Med Virol (1987) 0.86
Protective effect of protease inhibitors in influenza virus infected animals. Arch Virol (1982) 0.86
Proteolytic activation of influenza WSN virus in cultured cells is performed by homologous plasma enzymes. J Gen Virol (1982) 0.85
Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. Antiviral Res (1994) 0.84
Deoxycholate-mediated cleavage of the protein of Sendai virus nucleocapsid derived from infected cells. Biochem Biophys Res Commun (1974) 0.83
Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response. Vaccine (2008) 0.83
[Integration of influenza A virus NSP gene into baculovirus genome and its expression in insect cells]. Vopr Virusol (2010) 0.83
Intracellular cleavage of human influenza a virus hemagglutinin and its inhibition. Biochemistry (Mosc) (2003) 0.82
[Antiviral and therapeutic action of protease inhibitors in viral infections: experimental and clinical observations]. Vopr Virusol (1984) 0.81
Specific biochemical features of replication of clinical influenza viruses in human intestinal cell culture. Biochemistry (Mosc) (2007) 0.80
Covalent chromatography of influenza virus membrane M1 protein on activated thiopropyl Sepharose-6B. J Chromatogr B Biomed Sci Appl (1998) 0.78
[Interaction of influenza virus matrix protein M1 with histones]. Mol Biol (Mosk) (1997) 0.78
Alphavirus replication in cultured cells and infected animals is inhibited by antiproteinase agents. Antiviral Res (1986) 0.78
[Site-directed modification of caspase cleavage site regions in avian influenza virus proteins]. Vopr Virusol (2009) 0.77
[Localization of the influenza virus M1 matrix protein in the virion]. Mol Biol (Mosk) (2000) 0.77
Fatty acid acylated antibodies against virus suppress its reproduction in cells. FEBS Lett (1989) 0.77
[Pathogenic effect of pandemic influenza virus H1N1 under replication in cultures of human cells]. Vopr Virusol (2013) 0.77
[The phenomenon of proteolytic activation of myxoviruses and a new strategy for treating viral diseases]. Vopr Virusol (1983) 0.77
[Mechanism of hypotension induced by rifampicin during intravenous administration]. Antibiot Khimioter (1988) 0.77
[Key role of Asp16 in proteolysis of influenza A NP protein by caspases in infected cells]. Vopr Virusol (2004) 0.77
Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells. Biochem Mol Biol Int (1993) 0.77
Replication of influenza B virus in chicken embryos is suppressed by exogenous aprotinin. Arch Virol (1994) 0.76
Effective inhibition of viral reproduction by hydrophobised antiviral antibodies. Biomed Sci (1990) 0.76
[Clinical effectiveness of aprotinin aerosol in influenza and parainfluenza]. Vestn Ross Akad Med Nauk (1996) 0.76
[Enhancement of alphavirus reproduction in cell cultures at an alkaline pH]. Vopr Virusol (1987) 0.76
Hydrophobized antiviral antibodies and antisense oligonucleotides. Adv Enzyme Regul (1991) 0.75
[Identification of the protease-binding domain in the N-terminal region of the influenza A virus matrix protein M1]. Mol Biol (Mosk) (2001) 0.75
[General toxic and organotropic side-effects of cephalothin in acute and chronic experiments]. Antibiotiki (1981) 0.75
[Activity of the ionophore antibiotic 985-I in vitro and in vivo]. Dokl Akad Nauk SSSR (1988) 0.75
[pH-dependent rearrangements in the influenza A virus]. Vopr Virusol (2014) 0.75
[Adsorption on synthetic membranes and immunogenic properties of aprotinin cross-linked by glutaraldehyde]. Bioorg Khim (1999) 0.75
[Estimation of the efficacy of screened natural hypolipidemic compounds in a model of rabbit hypercholesterolemia]. Antibiot Khimioter (2004) 0.75
[Impact of administration rate parameter in toxicity test]. Antibiot Khimioter (2009) 0.75
[Experimental method for the quantitative assesment of the pain reaction occuring to the injection of drug preparations]. Antibiotiki (1977) 0.75
[Study of general toxic and organotropic properties of ampicillin combined with sulbactam]. Antibiot Khimioter (1992) 0.75
[Characteristics of elaboration of the bacterial endotoxins index relevant to antibiotic substances]. Antibiot Khimioter (2008) 0.75
[Mathematical analysis of the n-cholinolytic effects in experiments with the isolated frog rectus abdominis muscle]. Farmakol Toksikol (1976) 0.75
[Macrolide antibiotics and their use in combined pharmacotherapy]. Antibiot Khimioter (1989) 0.75
[Experimental study of human recombinant insulin]. Antibiot Khimioter (1992) 0.75
[Pharmacology of gentamicin sulfate]. Antibiotiki (1976) 0.75
[Biochemical features of protein matrix M1 of the influenza C virus]. Mol Biol (Mosk) (1993) 0.75
[Nerve-blocking properties of antibiotics]. Antibiotiki (1977) 0.75
[Hypotension caused by intravenous infusion of rifampicin and its relation to the administration schedule]. Antibiot Khimioter (1990) 0.75
[Effect of carfecillin on the body of animals in single and multiple administrations]. Antibiotiki (1980) 0.75
Relationship between the neuromuscular blocking effect of gentamicin and streptomycin and their concentration in blood. Acta Biol Med Ger (1977) 0.75
[Influenza virus proteins: preparation of a soluble M1 polypeptide by means of a stepwise deproteination of virions]. Mol Biol (Mosk) (1991) 0.75
[Effect of sisomicin i on elements of the peripheral nervous system]. Antibiotiki (1983) 0.75
[The anomalous isoelectric properties of influenza virus matrix protein M1]. Vopr Virusol (1991) 0.75
[NP gene of pandemic H1N1 virus attenuates virulence of mouse-adapted human influenza virus]. Vopr Virusol (2011) 0.75
[Mechanism of the peripheral myorelatant action of aminocyclitol antibiotics]. Antibiotiki (1976) 0.75
[Pharmacokinetics of amikacin in the perilymph and blood serum. An approach to the comparative evaluation of the potential ototoxicity of aminoglycoside antibiotics]. Antibiot Med Biotekhnol (1986) 0.75
[Biologic activity and tolerance of a preparation of polyunsaturated fatty acids, obtained by a microbiological route ["biopolyene"]]. Antibiot Khimioter (1992) 0.75
[Comparative study of the relationship between the blood concentration of gentamicin and streptomycin and their muscle-relaxing activity]. Antibiotiki (1975) 0.75
[The trypsin cleavage of hemagglutinin enhances the infectivity of the influenza virus in mice]. Vopr Virusol (1990) 0.75
[The therapeutic effect of aprotinin inhalations in influenza and paramyxovirus infections in mice]. Vopr Virusol (1993) 0.75
[The nature of the antagonism between aminocycletol antibiotics and acetylcholine]. Antibiotiki (1974) 0.75
[Study of general toxic and organotropic properties of clindamycin in long-term experiments]. Antibiot Khimioter (1992) 0.75
[Evolutionary changes in the NA and HA genes of H3N2 influenza virus in the Moscow Region during 2003-2009]. Vopr Virusol (2011) 0.75
[Pharmacokinetics of n-(5-oxynicotinoyl)-L-glutamic acid calcium salt upon bolus administration in rats and rabbits: interspecies extrapolation]. Eksp Klin Farmakol (2010) 0.75
[Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction]. Vopr Virusol (2011) 0.75
[Tolerance of gentacycol--a local dosage form of gentamicin based on collagen--animal experiments]. Antibiot Khimioter (1990) 0.75
[Experimental study of the pharmacological properties of amikacin]. Antibiot Med Biotekhnol (1985) 0.75
[Experimental study of the organotropic side-effect properties of polymyxin B]. Antibiotiki (1976) 0.75
[Influenza A virus M1 matrix protein is similar to protease inhibitors]. Dokl Akad Nauk (1999) 0.75
[Experimental study of protease C--proteolytic enzyme of microbial origin]. Antibiot Khimioter (1991) 0.75
[Procedure for determination of the pharmacopoeia requirement for "Anomalous toxicity" as applied to antibiotics]. Antibiot Khimioter (2008) 0.75
[Aprotinin antiviral aerosol: study of the local irritating and allergenic action after inhalation]. Antibiot Khimioter (1995) 0.75
[The effect of pH on in vitro deproteinization in orthomyxo- and paramyxoviruses]. Mol Gen Mikrobiol Virusol (1990) 0.75
[Inhibition of the reproduction of the influenza B virus by aprotinin]. Vopr Virusol (1992) 0.75
[General toxic and organotropic properties of cefotaxime in acute and chronic experiments]. Antibiot Khimioter (1990) 0.75
[General toxic and organotropic properties of azlocillin in acute and chronic experiments]. Antibiot Med Biotekhnol (1987) 0.75
[The pathogenetic therapy of acute respiratory diseases by aprotinin inhalations]. Ter Arkh (1995) 0.75
[Molecular mechanisms of proteolytic processing of viral proteins and the problem of antiviral chemotherapy and vaccine design]. Mol Biol (Mosk) (1988) 0.75
[Experimental and clinical data on the ototoxic properties of aminoglycoside antibiotics (aminocyclitols)]. Antibiotiki (1983) 0.75
[An analysis of the relationship between the serum concentration of streptomycin in experimental animals and its effect on the transmission of excitation at the neuromuscular synapses of skeletal musculature]. Antibiotiki (1974) 0.75
[Sisomycin pharmacokinetics in the perilymph and blood serum--an approach to predicting its ototoxic effect]. Antibiot Med Biotekhnol (1985) 0.75
[Estimate of hypothetical toxicity of drug combinations exemplified by two injection antibiotics]. Antibiot Khimioter (2011) 0.75
[Surface localization of amino acids in influenza virus hemagglutinin during functional transformation of virions by acidic pH]. Mol Biol (Mosk) (1996) 0.75
[Characterization of proteolytic cleavage of influenza virus nucleocapsid protein NP in infected cells]. Vopr Virusol (2000) 0.75
[General toxic and organotropic properties of sisomicin sulfate in chronic experiments on animals]. Antibiotiki (1983) 0.75